Uses for High-Cannabidiol Cannabis Extracts

"The Use of High-Cannabidiol Cannabis Extracts to Treat Epilepsy and Other Diseases"
2013-11-25 by Justin Kander, posted to [http://ezinearticles.com/?The-Use-of-High-Cannabidiol-Cannabis-Extracts-to-Treat-Epilepsy-and-Other-Diseases&id=8142665]:
There has been a dramatic rise in news attention to medicinal cannabis in 2013, with reports on CNN, ABC, CBS, and local publications about high-cannabidiol cannabis oil effectively controlling the symptoms of rare epileptic conditions like Dravet syndrome, Doose syndrome, infantile spasms, cortical dysplasia, and more. These diseases can cause hundreds to thousands of seizures a week, while also impairing development in a number of other ways. For families with children suffering from such conditions, the challenges are overwhelming. Due to the extremely complex nature of Dravet and related syndromes, traditional pharmaceuticals are ineffective and often make the problems worse. With no other hope, families have turned to high-CBD cannabis oil, which is proving to work with miraculous efficacy.
To clarify, high-CBD cannabis oil is non-psychoactive and apparently even more beneficial than high-THC cannabis oil. Cannabidiol is another cannabinoid in the cannabis plant, like the more well-known psychoactive cannabinoid THC, with significant research suggesting neuroprotectant, anticancer, antidiabetic, anti-ischemic, antispasmodic, antipsychotic, and antibacterial properties, among others. Furthermore, cannabis oil is a type of extract from cannabis. Such oil contains large amounts of concentrated cannabinoids that can be orally ingested rather than smoked, preserving the medicinal compounds and allowing them to be delivered through digestive system, rather than the respiratory system.
The research suggests that CBD has panacea-like properties, and in practice, this is proving to be the case. On August 11th, 2013, Sanjay Gupta released a documentary on CNN about Charlotte Figi. Charlotte is a young Dravet syndrome patient who was having 300 grand mal seizures a week. No pharmaceuticals or dietary changes could do anything to reduce this number. Charlotte's parents learned about high-CBD cannabis oil, and after literally the first dose, Charlotte's seizures stopped. She now has less than three minor seizures a month. This case is nothing short of miraculous, and it's not isolated. Dr. Margaret Gedde, a Colorado Springs physician, is tracking 11 new patients of the Stanely brothers, the providers of Charlotte's high-CBD medicine. 9 of them have had 90-100% reductions in seizures, which again, is simply miraculous.
The epileptic conditions that CBD is proving to be effective against are extremely complex, and not even the most powerful, well researched pharmaceuticals have been capable of inducing any healing. Yet high-CBD cannabis oil is immediately and potently reducing symptoms, with the only side effects being systemically beneficial - more energy, better learning, improved behavior, and more.
It should not be surprising that results like these have been going on for years. Just like research shows cannabinoids are therapeutically effective against epilepsy, there is research suggesting they can eliminate cancers and control other serious diseases. And in practice, for epilepsy and these other conditions, the results are translating to humans. People have been reliably eliminating cancers for years and mitigating diseases like diabetes, Crohn's, fibromyalgia, heart disease, chronic pain, multiple sclerosis, and more. This is as serious as it gets, and more attention must be brought to this issue.
As you can see, the use of medicinal cannabis is extremely important. This isn't about alleviating the side effects of chemotherapy or improving appetite - this is about putting serious diseases into remission, eliminating cancer in humans, and improving all aspects of human health. To see the scientific and experiential evidence supporting this, including medical documentation of terminal cancer patients now in remission, visit CannabisExtractReport.com.